UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primitive sarcoma of the breast: new insight on the proper surgical management

Journal of experimental & clinical cancer research, 2015-07, Vol.34 (1), p.72-72, Article 72

2015

Volltextzugriff (PDF)

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.3021-3021

2017

Volltextzugriff (PDF)

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT109-CT109

2016

Volltextzugriff (PDF)

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14005-e14005

2015

Volltextzugriff (PDF)

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Anticancer research, 2005-01, Vol.25 (1B), p.409-414

2005

Volltextzugriff (PDF)

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Oncology reports, 2012-05, Vol.27 (5), p.1377-1383

2012

Volltextzugriff (PDF)

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT301-CT301

2014

Volltextzugriff (PDF)

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5366-5366

2012

Volltextzugriff (PDF)

An unexpected neonatal outcome

Journal of Pregnancy and Reproduction, 2018, Vol.2 (3)

2018

Volltextzugriff (PDF)

The value of a single isolated CTG trace deceleration

Journal of Pregnancy and Reproduction, 2018, Vol.2 (3)

2018

Volltextzugriff (PDF)

An unusual tubal pregnancy implantation

Journal of Pregnancy and Reproduction, 2018, Vol.2 (3)

2018

Volltextzugriff (PDF)

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.537-537

2014

Volltextzugriff (PDF)

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5055-5055

2011

Volltextzugriff (PDF)

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e11041-e11041

2012

Volltextzugriff (PDF)

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.480-480

2013

Volltextzugriff (PDF)

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3722-3722

2010

Volltextzugriff (PDF)

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Oncology letters, 2013-04, Vol.5 (4), p.1117-1122

2013

Volltextzugriff (PDF)

Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier

Anti-cancer drugs, 2010-06, Vol.21 (5), p.559-564

2010

Volltextzugriff (PDF)

A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer

Gynecologic oncology, 2007-07, Vol.106 (1), p.164-169

2007

Volltextzugriff (PDF)

High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy

Experimental and therapeutic medicine, 2010-09, Vol.1 (5), p.867-872

2010

Volltextzugriff (PDF)

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer

Molecular and clinical oncology, 2014-05, Vol.2 (3), p.473-478

2014

Volltextzugriff (PDF)

Differential impact of body mass index on bone and breast density in post-menopausal women and potential implications for the risk of breast cancer

Endocrine Abstracts, 2019-05

2019

Volltextzugriff (PDF)

Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer

Anti-cancer drugs, 2003-09, Vol.14 (8), p.633-638

2003

Volltextzugriff (PDF)

Ifosfamide, cisplatin, and 13‐Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck

Cancer, 2001-08, Vol.92 (4), p.814-821

2001

Volltextzugriff (PDF)

Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer

Anticancer research, 1997-09, Vol.17 (5B), p.3761

1997

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(72)

Sprache

Englisch
(70)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(37)
Humans
(20)
Female
(15)
Male
(13)
Aged
(11)
Middle Aged
(11)
Nursing
(9)
Oncology
(9)
Surgery
(8)
General & Internal Medicine
(7)
Chemotherapy
(6)
Pediatrics
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Medicine, General & Internal
(5)
Mortality
(5)
Nurses
(5)
Qualitative Research
(5)
Quality Of Life
(5)
Studies
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Primitive sarcoma of the breast: new insight on the proper surgical management

Maintenance immunotherapy in stage IV cancer patients who have a clinical benefit from chemotherapy

Abstract CT109: Adjuvant ovarian suppression in high risk premenopausal breast cancer: ten-year follow-up of a phase I-II study

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study

Paclitaxel Plus Gemcitabine in Advanced Non-small Cell Lung Cancer Patients with Low Performance Status

Chemoembolization of unresectable hepatocellular carcinoma: Decreased toxicity with slow-release doxorubicin-eluting beads compared with lipiodol

Abstract CT301: Late disease recurrence in estrogen receptor positive (ER+) premenopausal breast cancer (BC)

Abstract 5366: Extended phase II study of maintenance immunotherapy in advanced cancer

An unexpected neonatal outcome

The value of a single isolated CTG trace deceleration

An unusual tubal pregnancy implantation

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study

Abstract 5055: The role of estrogens and vascular endothelial growth factor (VEGF) in premenopausal breast cancer carginogenesis and disease progression

A multicenter, open-label phase II trial of liposomal doxorubicin (LD) and docetaxel (DX), followed by concurrent chemotherapy and radiation therapy in locally advanced high-risk, early breast cancer (HRBC)

Abstract 480: Maintenance immunotherapy following carboplatin (CBDCA) - pemetrexed (PEM) chemotherapy in advanced adenocarcinoma (ADK) of the lung: A phase II study

Abstract 3722: Ovarian suppression with gonadotropin-releasing hormone analogues (Gn-RH) in high risk premenopausal breast cancer patients (PM-HR-BC): decrease of T regulatory cells (T-regs) and of vascular endothelial growth factor (VEGF)

Vascular endothelial growth factor expression and T-regulatory cells in premenopausal breast cancer

Liposomal pegylated doxorubicin and oxaliplatin as salvage chemotherapy in patients with metastatic gastric cancer treated earlier

A multicenter phase II study of pegylated liposomal doxorubicin and oxaliplatin in recurrent ovarian cancer

High-risk early breast cancer in patients under 40 years of age: Improved clinical outcome with total estrogen blockade and tailored chemotherapy

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer

Differential impact of body mass index on bone and breast density in post-menopausal women and potential implications for the risk of breast cancer

Phase I study of liposomal doxorubicin and oxaliplatin as salvage chemotherapy in advanced ovarian cancer

Ifosfamide, cisplatin, and 13‐Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck

Combined chemotherapy and differentiation therapy in the treatment of advanced non-small-cell lung cancer

Aktive Filter

Suchergebnisse filtern